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Background: Candida dubliniensis is a recently described opportunistic fungal pathogen that rarely infects the eye.
Reported cases of C. dubliniensis endophthalmitis have been of endogenous etiology and demonstrated recovery of
visual acuity with timely treatment. We herein report an unusual case of severe C. dubliniensis endophthalmitis
requiring enucleation.
Findings: This is a retrospective, descriptive case report with a brief literature review. A 41-year-old Caucasian man,
with a history of blunt trauma 8 months prior, presented to the emergency department with left eye pain and loss
of vision 2 days after complicated cataract surgery. He was first evaluated by an outside ophthalmologist 3 months
after trauma for left eye pain and progressive vision loss. He was found to have light perception vision with
non-granulomatous anterior uveitis but no sign of ruptured globe. A dense cataract developed while he was
treated with topical and subtenon's corticosteroids for which he underwent cataract surgery. Our examination
revealed no light perception vision with a relative afferent pupillary defect, elevated intraocular pressure, moderate
anterior chamber reaction, pupillary membrane, vitritis, and choroidal thickening on B-scan ultrasonography.
Diagnostic vitrectomy revealed purulent vitreal debris, retinal detachment with severe retinal necrosis, and choroidal
infiltrates. Operative fungal cultures grew C. dubliniensis. Despite intravitreal and systemic anti-fungal treatment,
vision and pain did not improve, resulting in subsequent enucleation.
Conclusion: C. dubliniensis endophthalmitis is uncommonly encountered and typically has reasonable visual
outcomes. This is the first reported case of C. dubliniensis, likely exogenous endophthalmitis, resulting in
enucleation, illustrating the potential virulence of this newly described organism.
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Introduction
Fungal endophthalmitis can occur via either endogenous
or exogenous route with Candida infections most com-
monly occurring from the endogenous route. Candida
infections are predominately caused by Candida albicans
species; however, several other species have been found
to be pathologic especially in the immunocompromised
state. Candida endogenous endophthalmitis often causes
severe vision loss but rarely results in enucleation. In a
study of 59 eyes with endogenous endophthalmitis, 56% of* Correspondence: nguyenj@wvuhealthcare.com
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in any medium, provided the original work is peyes with cultured positive yeast infection had a final
visual acuity outcome of 20/200 or better, and only 3
progressed to enucleation, all of which were secondary
to Aspergillus [1]. Exogenous fungal endophthalmitis is
associated with poorer visual acuity outcomes and
higher rates of enucleation given associated ocular
trauma and direct inoculation of the eye; however,
these cases are also most commonly caused by molds,
fusarium, or fungal species other than Candida [2,3].
Candida dubliniensis is a relatively newly described
species resulting in few reported cases of endogenous
endophthalmitis, and most patients have reasonable
visual acuity recovery [4-10]. We herein present an un-
usual case of severe C. dubliniensis endophthalmitis
that required enucleation.s an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 1 GMS stain illustrating hyphal elements.
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A 41-year-old Caucasian man presented to the emergency
department with left eye pain and loss of vision after com-
plicated cataract surgery 2 days prior. His past ocular his-
tory was significant for blunt trauma to the left eye with a
stick while riding an all-terrain vehicle 8 months ago; over
the following 3 months, the eye became painful with de-
terioration of vision for which he sought ophthalmic care.
At that initial examination, outside records indicated that
his vision was light perception, and there was significant
conjunctival injection, corneal edema, and anterior cham-
ber reaction precluding a view of the fundus. There was
no recorded sign of previous ocular trauma, keratic pre-
cipitates, hypopyon, or afferent pupillary defect, and his
poor vision was attributed to the inflammation from initial
injury. He was treated for non-granulomatous anterior
uveitis with topical and subtenon's corticosteroid injection
for several months. The lens developed progressive cataract
changes with corticosteroid treatment, and he underwent
cataract surgery that was complicated and unsuccessful
due to significant sequela from uveitic changes. An in-
traocular lens was not placed due to questionable lens
capsule integrity.
Our examination revealed a visual acuity of 20/30 right
eye (OD) and no light perception of the left eye (OS).
The right pupil was reactive to light, but the left pupil was
fixed and non-reactive, with a left relative afferent pupillary
defect. He had marked restriction of ocular motility of the
left eye due to pain. The left upper eyelid was ptotic and
edematous. The orbit was slightly tense to retropulsion, but
no proptosis was appreciated. The intraocular pressures
were 19 mmHg OD and 27 mmHg OS.
Slit-lamp biomicroscopy of the left eye revealed injected
and chemotic conjunctiva. The cornea was hazy with
diffuse fluorescein staining of the epithelium. The cata-
ract wound incision was intact, and Siedel test was
negative. The anterior chamber was without hypopyon,
but moderate cells and flare were seen. A pupillary
membrane precluded view to the fundus of the left eye.
The patient's vital signs were normal. Complete blood
count revealed an elevated white blood cell count
(11,300 cells per dL) without a left shift.
B-scan ultrasonography of the left eye revealed diffuse
vitritis and choroidal thickening. No retinal detachment
was seen. The patient was admitted to the hospital for
anterior chamber washout with removal of pupillary
membrane, diagnostic vitrectomy, and intravitreal injection
of vancomycin (1 mg/0.1 ml), ceftazidime (2.5 mg/0.1 ml),
dexamethasone (0.4 mg/0.1 ml), and amphotericin B
(0.4 mg/0.1 ml). Intraoperative findings included significant
fibrin anterior chamber reaction, purulent material filling
the vitreous cavity, funnel retinal detachment, and multiple
choroidal infiltrates. Retinal detachment repair was not
attempted due to the poor status of the retinal tissue.Initial gram stain revealed several polymorphonuclear
cells with rare budding yeast and very rare pseudohyphae.
Fungal culture subsequently revealed C. dubliniensis
sensitive to amphotericin, caspofungin, and fluconazole
(Figure 1). Serologic work-up for infection and inflam-
mation included blood culture, rapid plasma reagin,
fluorescent treponemal antibody-absorption, tuberculosis
quantiferon gold, chest X-ray, angiotensin-converting
enzyme, tick-borne disease panel, sedimentation rate,
C-reactive protein, and human leukocyte antigen B27
which all were within normal limits.
The patient was treated with fluconazole 800 mg daily
and evaluated by the infectious disease service who
found no signs of extra-ocular infection. He had a nor-
mal cardiac exam, and additional cardiac imaging was
not recommended by the infectious disease service. He
adamantly denied intravenous drug use but was found
to be hepatitis B and C positive without prior history
of vaccination. Human immunodeficiency virus testing
was negative, and hemoglobin A1c was 5.6. The patient
did not recover his vision and continued to experience
severe pain for which enucleation surgery was offered.
He underwent enucleation surgery with placement of a
porous implant without complication. He was treated
for 4 weeks with fluconazole and had an uneventful re-
covery at 3-month follow-up.
Discussion
Exogenous fungal endophthalmitis is usually caused by
preceding fungal keratitis, trauma, and intraocular surgery,
while endogenous fungal endophthalmitis is associated with
recent hospitalization, systemic surgery, immunocom-
promised status, presence of intravenous lines, cathe-
ters, or intravenous drug use, organ transplant, and
positive systemic cultures [11]. The mechanism of injury
in this case is most likely due to a traumatic exogenous
source in the setting of trauma. While he did not have
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side provider and the chronic use of corticosteroid may
have delayed the diagnosis of chronic fungal endoph-
thalmitis. The patient's hepatitis B and C infection
placed him at increased risk for an endogenous infec-
tion; however, he did not have needle tracks on physical
exam and a history of recent intravenous drug use along
with a positive blood culture to entirely suggest an en-
dogenous cause. Another potential exogenous source of
infection is from the cataract extraction 2 days prior to
presentation. While both the initial trauma and cataract
surgery could result in the infection, the typical latency
period of weeks to months (averaged 1.8 months) after
initial traumatic fungal inoculation may suggest that the
initial trauma being more likely. However, exogenous
fungal endophthalmitis, rare in the acute post-operative
period, has been shown to develop as early as within a
day of inoculation [2].
Over 77% of exogenous fungal endophthalmitis cases
are caused by molds with yeast as the second most com-
mon (23%), specifically C. albicans as the most prevalent
of the yeast species. There are, however, multiple species
of Candida which can result in systemic infection in de-
scending order of prevalence C. albicans (40%), Candida
glabrata (26%), Candida parapsilosis (14%), Candida
tropicalis (6%), Candida krusei (2%), Candida lusitanie
(1%), and C. dubliniensis (1%) [12]. Those typically as-
sociated with endophthalmitis include C. albicans and
C. tropicalis [1,11]. C. dubliniensis is a rare and newly
described organism initially discovered in 1995 in a
population of acquired immunodeficiency syndrome
patients in Dublin, Ireland [4]. It has been reported to
be pathogenic primarily in immunocompromised patients,
HIV, IV drug use, and neutropenic patients, and most
isolated strains are susceptible to azoles, amphotericin B,
and echinocandins [13]. However, in vitro studies have
indicated that resistance to fluconazole can develop with
long-term exposure due to overexpression of multidrug
transporter proteins in some C. dubliniensis isolates [8],
but has not been reported in clinical settings.
C. dubliniensis is closely related phenotypically with
C. albicans but can be differentiated by poor growth of
C. dubliniensis at elevated temperatures (42°C and
45°C), chromographic culture techniques illustrated by
CHROMagar Candida media (DRG International Inc.,
Springfield, NJ, USA) resulting in growth of dark green
C. dubliniensis colonies and more specifically by species-
specific polymerase chain reaction-enzyme immunoassay
techniques [14]. These new technologies are helping to
make the diagnosis of C. dubliniensis infections more
readily with a subsequent increase in reported cases. The
first case of endogenous C. dubliniensis endophthalmitis
was presented in 2008 in a healthy 38-year-old male with-
out immunosuppression or intravenous use history [5].Pelegrin et al. subsequently described another case of
endogenous C. dubliniensis endophthalmitis in a 41-year-
old HIV-infected intravenous drug abuser in Spain in
2009 with good recovery of vision from 20/400 to 20/80.
Espinosa-Heidmann et al. also reported a case of endogen-
ous C. dubliniensis endophthalmitis in a 27-year-old man
without immunosuppression with similar recovery of visual
acuity after treatment. Moloney and Park described an add-
itional five cases of C. dubliniensis endogenous endophthal-
mitis in patients with a history of IV drug use and hepatitis
C. Four patients had final visual outcome of 20/60 or better,
and one had hand motion vision. A last recent case pub-
lished by Rosenberger et al. again illustrated excellent visual
outcome of 20/25. While C. dubliniensis becomes an
established, although rare, causative agent of endogen-
ous fungal endophthalmitis, there has been no reported
case of exogenous etiology nor a severe case resulting in
enucleation upon our review.
In summary, we report the first case of C. dubliniensis
endophthalmitis leading to eventual enucleation and likely
the first case of exogenous etiology. While C. dubliniensis
endogenous endophthalmitis cases have reasonable visual
outcome, C. dubliniensis endophthalmitis can progress
to cause severe intraocular destruction with complete
loss of vision that requires enucleation, particularly in
exogenous cases.
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